United States · FDA National Drug Code directory

Nitrofurantoin (monohydrate/macrocrystals)

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
82804-115_ad3c1b1b-ca8b-4976-aba5-aed2f338dd92
Product NDC
82804-115
Form
CAPSULE
Composition / generic term
Nitrofurantoin (monohydrate/macrocrystals)
Labeler
Proficient Rx LP
Marketing category
ANDA
Marketing start / end (source format)
20230914
Source listing expiry
20261231

Source-listed ingredients

  • NITROFURANTOIN MONOHYDRATE — 75 mg/1
  • NITROFURANTOIN — 25 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 10 CAPSULE in 1 BOTTLE (82804-115-10) · 82804-115-10
  • 14 CAPSULE in 1 BOTTLE (82804-115-14) · 82804-115-14
  • 20 CAPSULE in 1 BOTTLE (82804-115-20) · 82804-115-20

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Nitrofurantoin (monohydrate/macrocrystals) — United States | Molindra Medicines